Abstract
Purpose
To investigate matrix metalloproteinase 9 (MMP-9) and WAVE3 expression in human colorectal cancer (CRC) and to evaluate their clinical significance.
Methods
We first performed real-time PCR to evaluate mRNA expression of MMP-9 and WAVE3 in 21 pairs of fresh CRC samples matched with adjacent normal mucosa. Then, MMP-9 and WAVE3 proteins were evaluated by immunohistochemistry on CRC tissue microarrays which included 216 CRC specimens and corresponding normal colorectal mucosa, and their correlation with clinicopathological factors and overall survival after surgery was evaluated.
Results
Both real-time PCR and immunohistochemistry evaluation have demonstrated that MMP-9 and WAVE3 were over-expressed in colorectal cancer tissues compared with normal mucosa (p < 0.001). MMP-9 expression was significantly higher in patients with low-grade differentiation and distant metastasis (p = 0.003 and p = 0.005, respectively), and patients with MMP-9-positive expression had a poorer prognosis (p = 0.008). However, patients with WAVE3-positive expression had a better prognosis (p = 0.039) and particularly favorable prognostic factors, including non-lymph node metastasis, non-distant metastasis, and early TNM stage (p = 0.029, 0.021, and 0.003, respectively). In addition, MMP-9-negative/WAVE3-positive patients had the best overall survival (p = 0.021). In multivariate survival analysis, MMP-9 expression and combined expression status of MMP-9/WAVE3 were identified as independent prognostic factors for CRC (p = 0.046 and p = 0.019, respectively).
Conclusions
Combined analysis of MMP-9 and WAVE3 has a significant value for assessing prognosis of CRC patients after surgery.
Similar content being viewed by others
References
Alkhateeb SS, Neill M, Bar-Moshe S, Rhijn BV, Kakiashvili DM, Fleshner N, Jewett M, Petein M, Schulman C, Hanna S, Bostrom PJ, Roumeguere T, Shariat SF, Rorive S, Zlotta AR (2011) Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guerin. Urol Ann 3(3):119–126. doi:10.4103/0974-7796.84954
Ambrosino C, Nebreda AR (2001) Cell cycle regulation by p38 MAP kinases. Biol Cell 93(1–2):47–51
Bendardaf R, Buhmeida A, Hilska M, Laato M, Syrjanen S, Syrjanen K, Collan Y, Pyrhonen S (2010) MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients. Cancer Invest 28(1):38–43. doi:10.3109/07357900802672761
Bulavin DV, Fornace AJ Jr (2004) p38 MAP kinase’s emerging role as a tumor suppressor. Adv Cancer Res 92:95–118. doi:10.1016/s0065-230x(04)92005-2
Chen F, Hanaoka N, Sato K, Fujinaga T, Sonobe M, Shoji T, Sakai H, Miyahara R, Bando T, Okubo K, Hirata T, Date H (2009) Prognostic factors of pulmonary metastasectomy for colorectal carcinomas. World J Surg 33(3):505–511. doi:10.1007/s00268-008-9875-3
Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N, Miki T, Gutkind JS (1995) The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81(7):1137–1146
Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB, Jiang H, Wang Y, Keating MT (2005) p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 19(10):1175–1187. doi:10.1101/gad.1306705
Fernando HS, Sanders AJ, Kynaston HG, Jiang WG (2008) WAVE1 is associated with invasiveness and growth of prostate cancer cells. J Urol 180(4):1515–1521. doi:10.1016/j.juro.2008.06.004
Hui L, Bakiri L, Stepniak E, Wagner EF (2007) p38alpha: a suppressor of cell proliferation and tumorigenesis. Cell Cycle 6(20):2429–2433
International Agency for Research on Cancer (IARC) (2010). Available from: http://www-depiarcfr/
Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52–67. doi:10.1016/j.cell.2010.03.015
Kim JH, Pyun JA, Lee KJ, Cho SW, Kwack KB (2011) Study on association between single nucleotide polymorphisms of MMP7, MMP8, MMP9 genes and development of gastric cancer and lymph node metastasis. Korean J Gastroenterol 58(5):245–251. doi:10.4166/kjg.2011.58.5.245
Kupferman ME, Fini ME, Muller WJ, Weber R, Cheng Y, Muschel RJ (2000) Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol 157(6):1777–1783. doi:10.1016/s0002-9440(10)64815-8
Kurisu S, Suetsugu S, Yamazaki D, Yamaguchi H, Takenawa T (2005) Rac-WAVE2 signaling is involved in the invasive and metastatic phenotypes of murine melanoma cells. Oncogene 24(8):1309–1319. doi:10.1038/sj.onc.1208177
Lee RJ, Albanese C, Stenger RJ, Watanabe G, Inghirami G, Haines GK, 3rd, Webster M, Muller WJ, Brugge JS, Davis RJ, Pestell RG (1999) pp60 (v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60 (v-src) signaling in breast cancer cells. J Biol Chem 274(11):7341–7350
Li J, Lau GK, Chen L, Dong SS, Lan HY, Huang XR, Li Y, Luk JM, Yuan YF, Guan XY (2011) Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One 6(7):e21816. doi:10.1371/journal.pone.0021816
Mahmoud N, Bullard Dunn K (2010) Metastasectomy for stage IV colorectal cancer. Dis Colon Rectum 53(7):1080–1092. doi:10.1007/DCR.0b013e3181dcadbc
Malliri A, van Es S, Huveneers S, Collard JG (2004) The Rac exchange factor Tiam1 is required for the establishment and maintenance of cadherin-based adhesions. J Biol Chem 279(29):30092–30098. doi:10.1074/jbc.M401192200
Martin TA, Pereira G, Watkins G, Mansel RE, Jiang WG (2008) N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer. Clin Exp Metastasis 25(2):97–108. doi:10.1007/s10585-007-9120-8
Mikami S, Katsube K, Oya M, Ishida M, Kosaka T, Mizuno R, Mukai M, Okada Y (2011) Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis. Lab Invest 91(10):1443–1458. doi:10.1038/labinvest.2011.111
Miki H, Fukuda M, Nishida E, Takenawa T (1999) Phosphorylation of WAVE downstream of mitogen-activated protein kinase signaling. J Biol Chem 274(39):27605–27609
Millard TH, Sharp SJ, Machesky LM (2004) Signalling to actin assembly via the WASP (Wiskott-Aldrich syndrome protein)-family proteins and the Arp2/3 complex. Biochem J 380(Pt 1):1–17. doi:10.1042/bj20040176
Minden A, Karin M (1997) Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta 1333(2):F85–104
O’Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96(19):1420–1425. doi:10.1093/jnci/djh275
Park KS, Kim SJ, Kim KH, Kim JC (2011) Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol 26(2):391–397. doi:10.1111/j.1440-1746.2010.06504.x
Recio JA, Merlino G (2002) Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Oncogene 21(7):1000–1008. doi:10.1038/sj.onc.1205150
Ricote M, Garcia-Tunon I, Bethencourt F, Fraile B, Onsurbe P, Paniagua R, Royuela M (2006) The p38 transduction pathway in prostatic neoplasia. J Pathol 208(3):401–407. doi:10.1002/path.1910
Roy R, Yang J, Moses MA (2009) Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27(31):5287–5297. doi:10.1200/jco.2009.23.5556
Sossey-Alaoui K, Su G, Malaj E, Roe B, Cowell JK (2002) WAVE3, an actin-polymerization gene, is truncated and inactivated as a result of a constitutional t (1:13) (q21:q12) chromosome translocation in a patient with ganglioneuroblastoma. Oncogene 21(38):5967–5974. doi:10.1038/sj.onc.1205734
Sossey-Alaoui K, Ranalli TA, Li X, Bakin AV, Cowell JK (2005) WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression. Exp Cell Res 308(1):135–145. doi:10.1016/j.yexcr.2005.04.011
Sossey-Alaoui K, Safina A, Li X, Vaughan MM, Hicks DG, Bakin AV, Cowell JK (2007) Down-regulation of WAVE3, a metastasis promoter gene, inhibits invasion and metastasis of breast cancer cells. Am J Pathol 170(6):2112–2121. doi:10.2353/ajpath.2007.060975
Sossey-Alaoui K, Bialkowska K, Plow EF (2009) The miR200 family of microRNAs regulates WAVE3-dependent cancer cell invasion. J Biol Chem 284(48):33019–33029. doi:10.1074/jbc.M109.034553
Sternlicht MD, Werb Z (1999) Guidebook to the extracellular matrix, anchor, and adhesion proteins. Sambrook. Oxford University Press, London, pp 519–538
Suetsugu S, Takenawa T (2003) Regulation of cortical actin networks in cell migration. Int Rev Cytol 229:245–286
Suetsugu S, Yamazaki D, Kurisu S, Takenawa T (2003) Differential roles of WAVE1 and WAVE2 in dorsal and peripheral ruffle formation for fibroblast cell migration. Dev Cell 5(4):595–609. doi:10.1016/S1534-5807(03)00297-1
Teng Y, Ren MQ, Cheney R, Sharma S, Cowell JK (2010) Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases. Br J Cancer 103(7):1066–1075. doi:10.1038/sj.bjc.6605850
Teng Y, Liu M, Cowell JK (2011) Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells. Int J Cancer 129(12):2825–2835. doi:10.1002/ijc.25964
Thornton TM, Rincon M (2009) Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int J Biol Sci 5(1):44–51
Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9(8):537–549. doi:10.1038/nrc2694
Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, Sahai E, Singer RH, Segall JE, Condeelis JS (2004) Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 64(23):8585–8594. doi:10.1158/0008-5472.can-04-1136
Acknowledgments
This study was supported by National Basic Research Program of China (973 Program, No 2010CB529403), Key Project of Capital Medical Development Fund (2009–2095), Beijing Academic Leaders Program (2009-2-18), Beijing Municipal Natural Science Foundation (7122030), Capital characteristic clinical application study special project (Z121107001012083), and Grant of Beijing Cancer Hospital (10-04).
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Zhang, Y., Guan, XY., Dong, B. et al. Expression of MMP-9 and WAVE3 in colorectal cancer and its relationship to clinicopathological features. J Cancer Res Clin Oncol 138, 2035–2044 (2012). https://doi.org/10.1007/s00432-012-1274-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-012-1274-3